The economic burden of diabetic retinopathy in Germany in 2002
The economic burden of diabetic retinopathy in Germany in 2002
复制标题
DOI：
10.1007/s00417-007-0573-x
复制
发表时间：
2008-01-01
影响因子：
2.7
通讯作者：
Watkins, Jessamy
中科院分区：
文献类型：
--
作者：
Happich, Michael;Reitberger, Ursula;Watkins, Jessamy
背景我们研究的目的是描述与糖尿病视网膜病变（DR）相关的费用，并评估其经济影响在德国。方法41德国眼科医生，随机选择从医生的数据库在德国，提供信息的成人1型和2型糖尿病患者DR（n=207）。这些信息包括2002年的社会人口统计学、临床特征和资源使用。国家一级的成本估计进行了计算，根据这些结果和DR的患病率数据在德国。结果本研究发现，与DR相关的费用往往会增加DR的进展，最高的增殖性DR患者和最低的轻度，非增殖性DR患者。德国法定健康保险（Gesetzliche Krankenversicherung，GKV）支付的所有付款人的总费用的三分之二。DR从社会的角度来看，总成本计算是一个元素的3.51亿美元的2002年，从GKV的角度来看，相当于是一个元素的2.23 bn.Conclusions这项研究是第一次全面的研究，以提供与DR在德国的成本估计。据估计，这些费用约占2002年保健总支出的1.5%。
Background The aims of our study were to describe the costs associated with diabetic retinopathy (DR), and to evaluate its economic impact in Germany.Methods Forty-one German ophthalmologists, randomly selected from a physicians' database in Germany, provided information on adult Type 1 and Type 2 diabetic patients with DR (n=207). This information included socio-demographics, clinical characteristics and resource use during the year 2002. National-level cost estimates were calculated, based on these results and the prevalence data on DR in Germany.Results This study found that costs associated with DR tend to increase as DR progresses, being highest in patients with proliferative DR and lowest in patients with mild, non-proliferative DR. The German statutory health insurance (Gesetzliche Krankenversicherung, GKV) covered two-thirds of the total costs paid by all the payers. The total cost of DR from a societal perspective was calculated at is an element of 3.51 bn for the year 2002, and from the GKV perspective amounted to is an element of 2.23 bn.Conclusions This study is the first comprehensive study to provide estimates of costs associated with DR in Germany. These costs were estimated to account for approximately 1.5% of the total health-care expenditure in 2002.